Analysis of Leukocyte Count Testing Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run. Technological advancement in devices for leukocyte testing provides momentum to the leukocyte count testing market with double-digit expected CAGR over forecast years.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
The increasing prevalence of the chronic disorder, cancer coupled with the growing adoption of digital devices to optimize patient care are the major factors expected to accelerate the market over forecast years. National Cancer Institute recorded that, in the U.S, around 1,735,350 new cases and around 609,640 deaths caused by cancer registered in 2018.
Other factors such as the significant increase in capital investments by the government and medical device manufacturers, technological advancements in mobile healthcare are also expected to propel the leukocyte count testing market in long run.
Besides, the benefits of testing at home, smartphone compatibility, user-friendliness, patient convenience of leukocyte count testing are also anticipated providing an optimistic growth to the market over the upcoming years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The number of smartphone users is growing at a substantial rate all over the world. For instance, according to ICEA (India Cellular and Electronics Association) report, there are over 500 million smartphone users in India by end of 2019 and this is also expected to reach 829 million by 2022. Increasing preference for telemedicine and at-home care by the patients and the clinicians is likely to increase the demand for the leukocyte count testing market over the forecast years.
The COVID19 pandemic had significantly impacted the leukocyte count testing market growth in 2020. Leukocyte count testing has been highly preferred during the pandemic to access the convenience healthcare solution in-home care settings. The pandemic also creates a tremendous opportunity for the market players to develop digital health solutions and expand their market reach.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The U.S. is anticipated to be the largest market for leukocyte count testing owing to its high adoption of advanced digital technology, awareness among the patients, well-developed healthcare infrastructure, and supportive government policies. The U.S leukocyte count testing market is likely to set considerable growth during the forecast period 2021-2031.
Like the U.S, Canada is also creating big opportunities for the market players in leukocyte count testing product launch and development. Meanwhile, many top U.S leukocyte count testing market leaders are expanding their facilities in Canada.
The current Covid-19 pandemic led to a revolution in leukocyte count testing adoption and innovation in Europe. The growing demand since early 2020 for leukocyte count testing and virtual care creates a huge opportunity for market growth in Europe.
Suitable government policies and regulations for the reimbursement of digital health applications are expected to boost the European leukocyte count testing market over forecast years. In addition, Germany is anticipated to share the largest market in terms of revenue owing to its national reimbursement policies on which over 73 million people accessing the digital health application in this country.
Some of the leading manufacturers and suppliers of leukocyte count testing include
Manufacturers in this market engaged in several industry development activities such as a new product launch, collaborations to hold their strong position in the global market. For instance, In March 2019, HemoCue launched an in-office hemoglobin count system in the U.S.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesPre Book
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Research Methodology -
An Adaptive Approach to Modern-day Research NeedsGet Methodology
Global demand for leukocyte count testing procedures is predicted to increase at a CAGR of 7.5% throughout the forecast period.
The rising incidence of chronic diseases such as cancer and the expanding use of digital technologies to improve patient care are boosting sales growth.
The North America leukocyte count testing market is developing rapidly due to the presence of well-established healthcare infrastructure, adoption of digital technologies, and awareness among patients.
Need An Exclusive Report For Your Unique Requirement?